<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68-ijerph-17-01395">
 <label>68.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Falzon</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Gandhi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Migliori</surname>
    <given-names>G.B.</given-names>
   </name>
   <name>
    <surname>Sotgiu</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Holtz</surname>
    <given-names>T.H.</given-names>
   </name>
   <name>
    <surname>Hollm-Delgado</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Keshavjee</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>DeRiemer</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Centis</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes</article-title>
  <source>Eur. Respir. J.</source>
  <year>2013</year>
  <volume>42</volume>
  <fpage>156</fpage>
  <lpage>168</lpage>
  <pub-id pub-id-type="doi">10.1183/09031936.00134712</pub-id>
  <?supplied-pmid 23100499?>
  <pub-id pub-id-type="pmid">23100499</pub-id>
 </element-citation>
</ref>
